PT UBC Medical Indonesia Tbk (LABS) Stock Statistics & Valuation Metrics
Total Valuation
PT UBC Medical Indonesia Tbk has a market cap or net worth of IDR 481.90B. The enterprise value is IDR 599.74B.
- Market Cap
- IDR 481.90B
- Enterprise Value
- IDR 599.74B
Share Statistics
PT UBC Medical Indonesia Tbk has 3,950,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,950,000,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PT UBC Medical Indonesia Tbk’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.64%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 8.64%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 3.69B
- Profits Per Employee
- 250.13M
- Employee Count
- 54
- Asset Turnover
- 0.87
- Inventory Turnover
- 1.69
Valuation Ratios
The current PE Ratio of PT UBC Medical Indonesia Tbk is 55.52. PT UBC Medical Indonesia Tbk’s PEG ratio is -61.07.
- PE Ratio
- 55.52
- PS Ratio
- 2.21
- PB Ratio
- 3.11
- Price to FCF
- -57.46
- Price to Operating Cash Flow
- 38.59
- PEG Ratio
- -61.07
Income Statement
In the last 12 months, PT UBC Medical Indonesia Tbk had revenue of 199.30B and earned 13.51B in profits. Earnings per share was 2.29.
- Revenue
- 199.30B
- Gross Profit
- 67.46B
- Operating Income
- 20.37B
- Pretax Income
- 17.52B
- Net Income
- 13.51B
- EBITDA
- 32.93B
- Earnings Per Share (EPS)
- 2.29
Cash Flow
In the last 12 months, operating cash flow was 12.27B and capital expenditures -20.51B, giving a free cash flow of -8.24B billion.
- Operating Cash Flow
- 12.27B
- Free Cash Flow
- -8.24B
- Free Cash Flow per Share
- -2.11
Dividends & Yields
PT UBC Medical Indonesia Tbk pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.74%
- Earnings Yield
- 1.84%
Stock Price Statistics
- Beta
- 0.50
- 52-Week Price Change
- -14.69%
- 50-Day Moving Average
- 152.86
- 200-Day Moving Average
- 152.43
- Relative Strength Index (RSI)
- 32.46
- Average Volume (3m)
- 3.54M
Important Dates
PT UBC Medical Indonesia Tbk upcoming earnings date is Apr 15, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 26, 2026
- Next Earnings Date
- Apr 15, 2027
- Ex-Dividend Date
- ―
Financial Position
PT UBC Medical Indonesia Tbk as a current ratio of 2.52, with Debt / Equity ratio of 18.04%
- Current Ratio
- 2.52
- Quick Ratio
- 1.44
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -0.41
- Interest Coverage Ratio
- 16.35
Taxes
In the past 12 months, PT UBC Medical Indonesia Tbk has paid 4.02B in taxes.
- Income Tax
- 4.02B
- Effective Tax Rate
- 0.23
Enterprise Valuation
PT UBC Medical Indonesia Tbk EV to EBITDA ratio is 16.60, with an EV/FCF ratio of -59.97.
- EV to Sales
- 2.30
- EV to EBITDA
- 16.60
- EV to Free Cash Flow
- -59.97
- EV to Operating Cash Flow
- 40.28
Balance Sheet
PT UBC Medical Indonesia Tbk has IDR 3.67B in cash and marketable securities with IDR 24.38B in debt, giving a net cash position of -IDR 20.71B billion.
- Cash & Marketable Securities
- IDR 3.67B
- Total Debt
- IDR 24.38B
- Net Cash
- -IDR 20.71B
- Net Cash Per Share
- -IDR 5.24
- Tangible Book Value Per Share
- IDR 38.10
Margins
Gross margin is 33.66%, with operating margin of 8.56%, and net profit margin of 4.07%.
- Gross Margin
- 33.66%
- Operating Margin
- 8.56%
- Pretax Margin
- 5.94%
- Net Profit Margin
- 4.07%
- EBITDA Margin
- 13.88%
- EBIT Margin
- 7.71%
Analyst Forecast
The average price target for PT UBC Medical Indonesia Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 21.38%
- EPS Growth Forecast
- -0.78%
